Kenneth W. Locke, Ph.D.
Chief Scientific Officer
Kenneth W. Locke serves as our Chief Scientific Officer with over 24 years of experience in the pharmaceutical industry. Prior to joining Lithera in May 2008, Dr. Locke progressively held the positions of Vice President, Research, Senior Vice President, Development Operations & Drug Discovery, Senior Vice President, Portfolio Management, Chief Business Officer and Chief Scientific Officer with MediciNova, Inc. starting in September 2000. Prior to joining MediciNova, he held the position of Vice President of Research at Tanabe Research Laboratories U.S.A., Inc. Dr. Locke joined Interneuron Pharmaceuticals, Inc. in 1989 as the Manager of Behavioral Neuroscience, taking on positions of increasing responsibility over the next 11 years. Earlier in his career, Dr. Locke headed laboratories for analgesic and anti-inflammatory drug research as well as Alzheimer's disease drug research at Hoechst-Roussel Pharmaceuticals, Inc. Dr. Locke earned a M.S. and a Ph.D. in Pharmacology from the Emory University School of Medicine. [Back to Management]
